4
Changes in Ownership
Tarsus Pharmaceuticals, Inc. Filed Acc 0000950170-24-097097
Director sold 35,000 shares at an average $26.08 ($912,961)
- Director disposed of 74,892 shares (other)
- Director acquired 37,562 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LINK WILLIAM J PHD Director | 2024-08-12 | Other disposition | −74,892 | 35,000 | I: show line 1 in the form | ||
| LINK WILLIAM J PHD Director | 2024-08-12 | Other acquisition | +10,446 | 10,446 | I: show line 2 in the form | ||
| LINK WILLIAM J PHD Director | 2024-08-12 | Other acquisition | +27,116 | 167,098 | D: show line 3 in the form | ||
| LINK WILLIAM J PHD Director | 2024-08-12 | Sale | −29,979 | $26.01 | $779,754 | 5,021 | I: show line 4 in the form |
| LINK WILLIAM J PHD Director | 2024-08-12 | Sale | −5,021 | $26.53 | $133,207 | 0 | I: show line 5 in the form |
| Open-market sales · 35,000 sh · avg $26.08 · $912,961 | |||||||
Loading xslF345X05/ownership.xml…